Login
Evidence Feed
About
Conferences
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
CANCER:
Kidney Medullary Carcinoma
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
‹
Kidney Cancer (361
)
Clear Cell Renal Cell Carcinoma (80
)
Kidney Cancer (361
)
Clear Cell Renal Cell Carcinoma (80
)
›
Associations
(3)
News
Twitter
Trials
Reset Filters
VERI cancer hierarchy
x
x
x
x
ARID2 H1495fs*8
Kidney Medullary Carcinoma
ARID2 H1495fs*8
Kidney Medullary Carcinoma
nivolumab
Sensitive: C4 – Case Studies
nivolumab
Sensitive
:
C4
nivolumab
Sensitive: C4 – Case Studies
nivolumab
Sensitive
:
C4
SMARCB1 deletion
Kidney Medullary Carcinoma
SMARCB1 deletion
Kidney Medullary Carcinoma
nivolumab
Sensitive: C4 – Case Studies
nivolumab
Sensitive
:
C4
nivolumab
Sensitive: C4 – Case Studies
nivolumab
Sensitive
:
C4
NF2 mutation
Kidney Medullary Carcinoma
NF2 mutation
Kidney Medullary Carcinoma
bevacizumab + erlotinib
Sensitive: C4 – Case Studies
bevacizumab + erlotinib
Sensitive
:
C4
bevacizumab + erlotinib
Sensitive: C4 – Case Studies
bevacizumab + erlotinib
Sensitive
:
C4
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login